{"id":"novolin-n","safety":{"commonSideEffects":[{"rate":null,"effect":"Hypoglycemia"},{"rate":null,"effect":"Weight gain"},{"rate":null,"effect":"Injection site reactions"},{"rate":null,"effect":"Lipodystrophy"}]},"_chembl":null,"_dailymed":{"setId":"e825d7e9-467c-4f50-a6d6-f2602449c1de","title":"NOVOLIN 70/30 (HUMAN INSULIN) INJECTION, SUSPENSION [A-S MEDICATION SOLUTIONS]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Novolin N (NPH insulin) is a suspension of insulin crystals complexed with protamine, which slows insulin absorption and extends its duration of action to 24 hours. It mimics the basal insulin secretion pattern of the pancreas, allowing sustained glucose control between meals and overnight. The drug works by activating insulin receptors on muscle, fat, and liver cells to promote glucose uptake and storage.","oneSentence":"Novolin N is an intermediate-acting insulin that binds to insulin receptors on cells to facilitate glucose uptake and utilization, lowering blood glucose levels.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T05:20:40.464Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Type 1 diabetes mellitus"},{"name":"Type 2 diabetes mellitus"}]},"trialDetails":[{"nctId":"NCT02556840","phase":"NA","title":"Impact on Birth Weight of Two Therapeutic Strategies (Insulin Therapy From the Beginning of Pregnancy vs. Insulin Therapy Initiated According to Fetal Growth Evaluated by Ultrasonography Measurements) in Pregnant Women With Monogenic Diabetes","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2016-04-25","conditions":"Maturity-Onset Diabetes of the Young","enrollment":46},{"nctId":"NCT04128995","phase":"PHASE4","title":"Surgical or Medical Treatment","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2019-12-15","conditions":"Diabetes Mellitus, Type 2, Pediatric Obesity, Bariatric Surgery Candidate","enrollment":88},{"nctId":"NCT05781711","phase":"PHASE2","title":"Clinical Study to Evaluate the Possible Efficacy of Metformin in Patients With Parkinson's Disease","status":"COMPLETED","sponsor":"Tanta University","startDate":"2023-01-06","conditions":"Parkinson Disease","enrollment":60},{"nctId":"NCT03878706","phase":"","title":"The Cardiovascular Effect of GLP-1 Agonist, SGLT2 Inhibitor and Their Combination","status":"RECRUITING","sponsor":"University of Athens","startDate":"2017-11-03","conditions":"Diabetes Mellitus, Type 2","enrollment":240},{"nctId":"NCT06747468","phase":"PHASE3","title":"Avexitide for Treatment of Post-Bariatric Hypoglycemia","status":"ACTIVE_NOT_RECRUITING","sponsor":"Amylyx Pharmaceuticals Inc.","startDate":"2025-04-29","conditions":"Post Bariatric Hypoglycemia","enrollment":75},{"nctId":"NCT05042505","phase":"NA","title":"Effect of Dapagliflozin vs Sitagliptin on Liver Fat Accumulation and Body Composition in Patients With Diabetes Mellitus and Liver Transplantation","status":"COMPLETED","sponsor":"Medanta, The Medicity, India","startDate":"2022-01-01","conditions":"Diabetes Mellitus, Liver Transplant; Complications","enrollment":100},{"nctId":"NCT07371169","phase":"NA","title":"Efficacy of Chromium Picolinate in Reducing Acanthosis Nigricans Severity in Adolescents With Insulin Resistance","status":"COMPLETED","sponsor":"Uruk University","startDate":"2025-01-01","conditions":"Insulin Resistance, Acanthosis Nigricans","enrollment":90},{"nctId":"NCT05660083","phase":"PHASE2","title":"Alpelisib/iNOS Inhibitor/Nab-paclitaxel in Patients With HER2 Negative Metaplastic Breast Cancer (MpBC)","status":"RECRUITING","sponsor":"The Methodist Hospital Research Institute","startDate":"2023-01-12","conditions":"HER2-negative Breast Cancer, Metastatic Breast Cancer, Metaplastic Breast Carcinoma","enrollment":36},{"nctId":"NCT06445946","phase":"PHASE4","title":"DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational Diabetes","status":"RECRUITING","sponsor":"Ohio State University","startDate":"2024-08-01","conditions":"Gestational Diabetes Mellitus, Pregnancy, High Risk","enrollment":1572},{"nctId":"NCT03864068","phase":"PHASE2","title":"Inositol Supplementation to Treat PCOS (INSUPP-PCOS)","status":"COMPLETED","sponsor":"Milton S. Hershey Medical Center","startDate":"2020-01-24","conditions":"Polycystic Ovary Syndrome, Anovulation, Hyperandrogenism","enrollment":154},{"nctId":"NCT07255807","phase":"NA","title":"Defining the Human Insulin Resistance Molecular Network; SIGNATURE","status":"NOT_YET_RECRUITING","sponsor":"University of Copenhagen","startDate":"2025-12-01","conditions":"Metabolic Health, Insulin Sensitivity/Resistance","enrollment":80},{"nctId":"NCT05206877","phase":"PHASE1","title":"Topical Insulin for Glaucoma","status":"RECRUITING","sponsor":"Stanford University","startDate":"2022-04-01","conditions":"Glaucoma","enrollment":52},{"nctId":"NCT00617435","phase":"NA","title":"Impact of Trans Fatty Acids From Natural and Industrial Origin in the Induction of Insulin Resistance Development","status":"COMPLETED","sponsor":"Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement","startDate":"2007-10","conditions":"Insulin Resistance, Obesity","enrollment":66},{"nctId":"NCT07087184","phase":"NA","title":"Gauging Outcomes of Total Milk Ingestion on Lipid and gControl","status":"RECRUITING","sponsor":"University of California, San Francisco","startDate":"2025-07-24","conditions":"Heart Diseases, Cardiovascular Disease","enrollment":100},{"nctId":"NCT05251207","phase":"NA","title":"Plasma Trimethylamine N-oxide Elevation Induced by L-carnitine Supplementation and Insulin Resistance","status":"ACTIVE_NOT_RECRUITING","sponsor":"Poznan University of Physical Education","startDate":"2022-02-07","conditions":"Insulin Resistance","enrollment":40},{"nctId":"NCT01493934","phase":"PHASE1, PHASE2","title":"Development of a Fast Measurement Technique of Insulin Resistance in Human","status":"COMPLETED","sponsor":"Institut National de la Santé Et de la Recherche Médicale, France","startDate":"2010-04","conditions":"Type 2 Diabetes Mellitus","enrollment":12},{"nctId":"NCT05293366","phase":"","title":"LOng COvid COmorbidities: Endocrine,Metabolic,Neuropsychiatric,Muscle,Cardiovascular,Pulmonary,Dermatologic Dysfunctions","status":"RECRUITING","sponsor":"Federico II University","startDate":"2022-01-27","conditions":"Long Covid-19","enrollment":100},{"nctId":"NCT06836128","phase":"PHASE3","title":"The Combined Effect of N-Acetyl Cysteine and Metformin in Polycystic Ovary Syndrome Patients","status":"RECRUITING","sponsor":"Cairo University","startDate":"2025-03-01","conditions":"Polycystic Ovary Syndrome","enrollment":102},{"nctId":"NCT03229408","phase":"PHASE2","title":"Treating Inflammation in Polycystic Ovary Syndrome to Ameliorate Ovarian Dysfunction","status":"COMPLETED","sponsor":"University of Illinois at Chicago","startDate":"2018-12-05","conditions":"Polycystic Ovary Syndrome","enrollment":60},{"nctId":"NCT04764162","phase":"NA","title":"Choline and Cardiometabolic Health","status":"COMPLETED","sponsor":"Virginia Polytechnic Institute and State University","startDate":"2021-08-20","conditions":"Cardiovascular Risk Factor","enrollment":14},{"nctId":"NCT06999551","phase":"PHASE4","title":"Comparison of the Efficacy and Safety of GLARGEN® Versus NPH Insulin in Diabetic Tunisian Patients.","status":"NOT_YET_RECRUITING","sponsor":"Les Laboratoires des Médicaments Stériles","startDate":"2025-07-01","conditions":"Diabetes Mellitus","enrollment":60},{"nctId":"NCT06888167","phase":"NA","title":"Food (poly)phenol Metabotypes and Beta-cell Mass and Function.","status":"RECRUITING","sponsor":"Azienda Ospedaliero-Universitaria di Parma","startDate":"2024-10-14","conditions":"Healthy Volunteer","enrollment":40},{"nctId":"NCT04763265","phase":"PHASE2","title":"Study to Compare 2 Botulinum Type A Toxins in the Treatment of Glabellar Frown Lines","status":"COMPLETED","sponsor":"Croma-Pharma GmbH","startDate":"2020-06-24","conditions":"Frown Lines","enrollment":208},{"nctId":"NCT04979377","phase":"","title":"Prevalence of Hyperandrogenism in Type 1 Diabetes","status":"COMPLETED","sponsor":"Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal","startDate":"2020-03-09","conditions":"Type 1 Diabetes, Polycystic Ovary Syndrome, Hyperandrogenism","enrollment":150},{"nctId":"NCT06671340","phase":"NA","title":"Chronic Dorzagliatin on Insulin and Incretin Function in Intermediate Hyperglycemia and Type 2 Diabetes","status":"NOT_YET_RECRUITING","sponsor":"Elaine Chow","startDate":"2025-04-02","conditions":"Diabetes Mellitus, Prediabetes / Type 2 Diabetes","enrollment":30},{"nctId":"NCT06855615","phase":"PHASE4","title":"Comparison of Thrice-Daily Premixed Human Insulin with Basal-Bolus Therapy Among Patients with Poorly Controlled Type 2 Diabetes Mellitus","status":"COMPLETED","sponsor":"Hospital Sultanah Aminah Johor Bahru","startDate":"2020-10-01","conditions":"Type 2 Diabetes Mellitus (T2DM)","enrollment":44},{"nctId":"NCT06386783","phase":"PHASE3","title":"Fentanyl Versus Dexmedetomidine as an Adjuvant to Bupivacaine in Spinal Anesthesia ; Peritoneal Symptomatic Effects","status":"RECRUITING","sponsor":"Aswan University","startDate":"2023-07-01","conditions":"Dexmedetomidine, Fentanyl","enrollment":148},{"nctId":"NCT03960333","phase":"","title":"Immunometabolism in Pediatric Obesity","status":"COMPLETED","sponsor":"Arkansas Children's Hospital Research Institute","startDate":"2019-04-25","conditions":"Obesity, Type 2 Diabetes Mellitus, Insulin Resistance","enrollment":82},{"nctId":"NCT03323294","phase":"","title":"Bioenergetics and Metabolism in Pediatric Populations","status":"COMPLETED","sponsor":"Arkansas Children's Hospital Research Institute","startDate":"2017-10-18","conditions":"Obesity, Type 2 Diabetes Mellitus, Insulin Resistance","enrollment":79},{"nctId":"NCT05368402","phase":"PHASE2","title":"Clinical Trial on Ladarixin Adjunctive Therapy to Improve Glycemic Control in Type 1 Diabetes.","status":"TERMINATED","sponsor":"Dompé Farmaceutici S.p.A","startDate":"2022-09-14","conditions":"Type 1 Diabetes","enrollment":3},{"nctId":"NCT05792540","phase":"PHASE2","title":"Clinical Study to Evaluate the Possible Efficacy of Dapagliflozin and Atorvastatin in Patients With Major Depressive Disorders","status":"COMPLETED","sponsor":"Tanta University","startDate":"2023-06-06","conditions":"Depressive Disorder","enrollment":75},{"nctId":"NCT05768191","phase":"PHASE4","title":"Comparative Efficacy of a Two Daily Mixed Insulin Injection Versus a Basal-bolus Scheme With Human Insulin","status":"COMPLETED","sponsor":"Université NAZI BONI","startDate":"2023-06-15","conditions":"Type 1 Diabetes","enrollment":22},{"nctId":"NCT05289986","phase":"PHASE4","title":"The Effect on Lipid Profile of Switching to Delstrigo in HIV Positive Patients","status":"TERMINATED","sponsor":"Chelsea and Westminster NHS Foundation Trust","startDate":"2023-11-21","conditions":"Hiv","enrollment":18},{"nctId":"NCT06677788","phase":"PHASE2","title":"Evaluating the Efficacy and Safety of Roflumilast in Patients with NASH","status":"COMPLETED","sponsor":"Tanta University","startDate":"2022-04-01","conditions":"Non-Alcoholic Steatohepatitis (NASH)","enrollment":55},{"nctId":"NCT05589584","phase":"PHASE3","title":"N-acetyl Cysteine and Patients with Non-alcoholic Fatty Liver Disease","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2022-11-01","conditions":"Simple Steatosis Non Fatty Liver","enrollment":60},{"nctId":"NCT06622616","phase":"NA","title":"NUTRITIONAL INTERVENTION STUDY to EVALUATE the EFFECT of ACHETA DOMESTICUS POWDER CONSUMPTION on GLUCOSE HOMEOSTASIS and INTESTINAL DYSBIOSIS in HEALTHY and PREDIABETIC POPULATION.","status":"NOT_YET_RECRUITING","sponsor":"María Isabel Espinosa","startDate":"2025-01","conditions":"Insulin Resistance, Type 2 Diabetes Mellitus with Features of Insulin Resistance","enrollment":120},{"nctId":"NCT06619301","phase":"PHASE3","title":"RCT Glargine vs NPH for Treatment of DM in Pregnancy","status":"RECRUITING","sponsor":"Loyola University","startDate":"2024-04-01","conditions":"Diabetes Mellitus in Pregnancy, Type 2 Diabetes Mellitus (T2DM), Gestational Diabetes Mellitus, Class A2","enrollment":160},{"nctId":"NCT04118920","phase":"PHASE1","title":"Safety of Topical Insulin Drops for Open-angle Glaucoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Centre hospitalier de l'Université de Montréal (CHUM)","startDate":"2023-03-27","conditions":"Glaucoma","enrollment":18},{"nctId":"NCT06498102","phase":"NA","title":"Time-restricted Feeding Improves Basal Fat Oxidation and Body Composition But Not Fat Oxidation During Exercise","status":"COMPLETED","sponsor":"Hacettepe University","startDate":"2022-06-06","conditions":"Dietary Exposure","enrollment":34},{"nctId":"NCT06363916","phase":"","title":"Evaluation of Security and Efficacy of Medtrum Hybrid Closed Loop System","status":"RECRUITING","sponsor":"Medtrum France","startDate":"2024-04-15","conditions":"Type 1 Diabetes","enrollment":160},{"nctId":"NCT06319768","phase":"NA","title":"Efficacy of Intralesional Injection of Pentoxifylline, Platelet-Rich Plasma, and Combined Pentoxifylline With Platelet-Rich Plasma in Patients With Atrophic Acne Scars","status":"RECRUITING","sponsor":"Sohag University","startDate":"2024-01-01","conditions":"Atrophic Acne Scar","enrollment":75},{"nctId":"NCT06119035","phase":"NA","title":"Insulin Modelling Based on Plasma Glucose Measures Via a Minimally-Invasive Glucose Sensor","status":"COMPLETED","sponsor":"Singapore Institute of Food and Biotechnology Innovation","startDate":"2023-11-06","conditions":"PreDiabetes","enrollment":20},{"nctId":"NCT06230146","phase":"PHASE1, PHASE2","title":"Efficacy and Safety of Fractional CO2 Laser Combined With Intralesional Insulin, Botulinum Toxin or Triamcinolone Acetonide in the Treatment of Keloid: A Clinical, Dermoscopic and Immunohistochemical Study.","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2024-05-01","conditions":"Keloid","enrollment":45},{"nctId":"NCT06203275","phase":"PHASE3","title":"The G Protein-Coupled Receptor Kinase Type 2 Inhibitor Paroxetine as Adjunctive Therapy to Improve Insulin Sensitivity in Patients With Type 2 Diabetes Mellitus","status":"UNKNOWN","sponsor":"aya ramadan ashmawy sarhan","startDate":"2024-01","conditions":"Diabetes Mellitus, Type 2","enrollment":44},{"nctId":"NCT00383877","phase":"PHASE3","title":"Effect of Insulin Detemir on Blood Glucose Control in Subjects With Type 2 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2006-09","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":263},{"nctId":"NCT05035368","phase":"PHASE2","title":"Ladarixin as Adjunctive Therapy to Improve Insulin Sensitivity and Glucometabolic Outcomes in Type 1 Diabetes","status":"WITHDRAWN","sponsor":"Dompé Farmaceutici S.p.A","startDate":"2021-09-30","conditions":"Type I Diabetes","enrollment":""},{"nctId":"NCT00313742","phase":"PHASE4","title":"The Effect of Exercise on Blood Glucose Levels in Patients With Type 1 Diabetes: A Comparison of 3 Long-acting Insulins","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2006-04","conditions":"Diabetes, Diabetes Mellitus, Type 1","enrollment":51},{"nctId":"NCT00504673","phase":"PHASE3","title":"Comparison of Insulin Detemir Versus Insulin NPH on Weight Change in Overweight and Obese With Type 2 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2005-04","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":277},{"nctId":"NCT00687453","phase":"PHASE4","title":"Insulin Glargine Versus Twice-Daily NPH","status":"TERMINATED","sponsor":"Charles Drew University of Medicine and Science","startDate":"2003-02","conditions":"Type 2 Diabetes Mellitus","enrollment":27},{"nctId":"NCT00521690","phase":"PHASE4","title":"The Effect of Insulin Detemir on Blood Glucose Control in Taiwanese Patients With Type 2 Diabetes Failing on OAD","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2006-12","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":25},{"nctId":"NCT05124457","phase":"PHASE2","title":"DETERMINE: Detemir vs NPH","status":"RECRUITING","sponsor":"University of California, Los Angeles","startDate":"2022-02-01","conditions":"Gestational Diabetes, Diabetes Mellitus, Type 2","enrollment":336},{"nctId":"NCT03771261","phase":"NA","title":"Balanced (Egg) Protein During Obesity Reduction: Differential Responses of Insulin Resistance by Race","status":"COMPLETED","sponsor":"Duke University","startDate":"2018-06-15","conditions":"Pre Diabetes, Obesity","enrollment":99},{"nctId":"NCT00506662","phase":"PHASE4","title":"Comparison of Insulin Detemir and NPH Insulin Given Once Daily in Ageing Subjects With Type 2 Diabetes","status":"TERMINATED","sponsor":"Novo Nordisk A/S","startDate":"2007-07","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":86},{"nctId":"NCT02036372","phase":"NA","title":"Perioperative Insulin, GIK or GLP-1 Treatment in Diabetes Mellitus","status":"COMPLETED","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","startDate":"2014-01","conditions":"Diabetes Mellitus Type II","enrollment":150},{"nctId":"NCT05389813","phase":"PHASE2, PHASE3","title":"Comparison Between Oxycodone and Pregabalin as Preemptive Analgesia","status":"UNKNOWN","sponsor":"An-Najah National University","startDate":"2021-08-15","conditions":"Anesthesia","enrollment":150},{"nctId":"NCT01308437","phase":"PHASE3","title":"Immunosafety Study of Recombinant Human Insulins in Type 1 Diabetics","status":"TERMINATED","sponsor":"Wockhardt","startDate":"2011-03","conditions":"Type I Diabetes","enrollment":134},{"nctId":"NCT01409330","phase":"NA","title":"German Diabetes-Diet-Intervention and Energy Restriction-Trial (DDIET)","status":"COMPLETED","sponsor":"German Diabetes Center","startDate":"2011-02","conditions":"Type 2 Diabetes","enrollment":40},{"nctId":"NCT05885633","phase":"NA","title":"Endometrial Vitamin D Receptor in PCOS","status":"COMPLETED","sponsor":"Uşak University","startDate":"2022-10-21","conditions":"Vitamin D Receptor Defect","enrollment":64},{"nctId":"NCT00788840","phase":"PHASE4","title":"Detemir Energy Expenditure Study","status":"COMPLETED","sponsor":"University of Surrey","startDate":"2008-01","conditions":"Type 2 Diabetes Mellitus, Obesity","enrollment":30},{"nctId":"NCT04477109","phase":"NA","title":"Effectiveness of Low Level Laser Therapy on Insulin Resistance and Inflammatory Biomarkers","status":"COMPLETED","sponsor":"Cairo University","startDate":"2020-07-01","conditions":"Insulin Resistance, Inflammatory Markers","enrollment":60},{"nctId":"NCT04240171","phase":"","title":"Dapagliflozin Versus Glimepiride Effect in Patient With Type 2 Diabetes Mellitus","status":"COMPLETED","sponsor":"Damanhour University","startDate":"2020-12-01","conditions":"Diabetes Mellitus, Type 2","enrollment":60},{"nctId":"NCT03784287","phase":"PHASE2","title":"A Treatment Extension Study of Mucopolysaccharidosis Type IIIB","status":"UNKNOWN","sponsor":"Allievex Corporation","startDate":"2018-02-19","conditions":"Mucopolysaccharidosis Type IIIB, MPS III B","enrollment":20},{"nctId":"NCT05679037","phase":"PHASE3","title":"Role of Alpha-lipoic Acid in Diabetes Melitus Type 1","status":"UNKNOWN","sponsor":"Tanta University","startDate":"2023-01","conditions":"Diabetes MellitusType 1","enrollment":52},{"nctId":"NCT05612282","phase":"","title":"The Impact of the Distribution of Adipose Tissue on the Occurrence of Metabolic Disorders and the Level of Cardiopulmonary Fitness","status":"COMPLETED","sponsor":"Medical University of Bialystok","startDate":"2016-11-11","conditions":"Obesity, Abdominal","enrollment":91},{"nctId":"NCT01053234","phase":"NA","title":"Different Insulin Regimens and Postprandial Coagulation Activation","status":"COMPLETED","sponsor":"Esbjerg Hospital - University Hospital of Southern Denmark","startDate":"2007-02","conditions":"Type 2 Diabetes, Cardiovascular Risk, Hemostasis","enrollment":78},{"nctId":"NCT05572060","phase":"NA","title":"Effect of Metformin Use on Mortality in Diabetic and Non Diabetic Patients With Sepsis and Septic Shock.","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2022-12-01","conditions":"Septic Shock","enrollment":75},{"nctId":"NCT05565976","phase":"PHASE2, PHASE3","title":"Dapagliflozin Effect in Cognitive Impairment in Stroke Trial","status":"UNKNOWN","sponsor":"Jaime Daniel Mondragon","startDate":"2020-08-01","conditions":"Stroke, Ischemic, Mild Cognitive Impairment, Dementia, Vascular","enrollment":270},{"nctId":"NCT05558488","phase":"NA","title":"The Effect of a Meatless,Keto Restrictive Diet on Body Composition,Strength Capacity,Oxidative Stress,Immune Response","status":"COMPLETED","sponsor":"Katarzyna Siedzik","startDate":"2019-10-01","conditions":"Body Weight, Oxidative Stress, Trimethylamine N-oxide","enrollment":14},{"nctId":"NCT01963728","phase":"PHASE4","title":"Comparison of Insulin Therapy in Treating Post-Transplant Diabetes","status":"TERMINATED","sponsor":"Inova Health Care Services","startDate":"2013-11-27","conditions":"Diabetes Mellitus","enrollment":2},{"nctId":"NCT05461365","phase":"PHASE3","title":"Intranasal Insulin for COVID-19-related Smell Loss","status":"COMPLETED","sponsor":"Universidad Panamericana","startDate":"2021-01-04","conditions":"Anosmia, Smell Loss, Paraosmia","enrollment":27},{"nctId":"NCT01613807","phase":"PHASE4","title":"Humalog® Mix50/50(tm) as a Treatment for Gestational Diabetes","status":"COMPLETED","sponsor":"Sansum Diabetes Research Institute","startDate":"2008-10","conditions":"Gestational Diabetes Mellitus","enrollment":40},{"nctId":"NCT02967224","phase":"PHASE4","title":"A \"Real World\" Trial to Determine Efficacy and Health Outcomes of Toujeo Compared to \"Standard of Care\" Basal Insulins in Insulin Naïve Patients Initiating Insulin","status":"COMPLETED","sponsor":"Sanofi","startDate":"2015-11-05","conditions":"Diabetes Mellitus, Type 2","enrollment":705},{"nctId":"NCT02967211","phase":"PHASE4","title":"A \"Real World\" Trial to Determine Efficacy and Health Outcomes of Toujeo Compared to \"Standard of Care\" Basal Insulin in Patients Already Using Basal Insulin","status":"COMPLETED","sponsor":"Sanofi","startDate":"2015-12-21","conditions":"Diabetes Mellitus, Type 2","enrollment":609},{"nctId":"NCT03312478","phase":"PHASE4","title":"Association of Type 1 Diabetes Mellitus in Offsprings With Positive Parental History of Diabetes","status":"COMPLETED","sponsor":"Sanofi","startDate":"2017-10-13","conditions":"Type 1 Diabetes","enrollment":375},{"nctId":"NCT02910518","phase":"PHASE1","title":"A Study to Demonstrate Bioequivalence Between Insulin Glulisine U300 and Insulin Glulisine U100 After a Single Subcutaneous Dose Using the Euglycemic Clamp Technique, in Patients With Type 1 Diabetes Mellitus","status":"COMPLETED","sponsor":"Sanofi","startDate":"2017-02-17","conditions":"Type1 Diabetes Mellitus","enrollment":44},{"nctId":"NCT05317559","phase":"NA","title":"Cardiometabolic Outcomes With Light Exposure During Sleep","status":"COMPLETED","sponsor":"Northwestern University","startDate":"2014-02","conditions":"Light","enrollment":20},{"nctId":"NCT02947503","phase":"PHASE3","title":"Pregnancy Outcomes: Effects of Metformin Study (POEM Study)","status":"RECRUITING","sponsor":"Bethesda Diabetes Research Center","startDate":"2019-11-26","conditions":"Gestational Diabetes, Insulin Resistance","enrollment":500},{"nctId":"NCT04834362","phase":"PHASE4","title":"Insulin for Hyperglycemia in Stroke Trial","status":"COMPLETED","sponsor":"National Institute of Neurosciences and Hospital, Dhaka","startDate":"2021-04-05","conditions":"Hyperglycemia, Stroke, Acute","enrollment":452},{"nctId":"NCT03350984","phase":"PHASE4","title":"Insulin Schemes for Type 2 Diabetes Control","status":"COMPLETED","sponsor":"Universidad de Guanajuato","startDate":"2017-11-02","conditions":"Type 2 Diabetes Mellitus","enrollment":75},{"nctId":"NCT04213300","phase":"","title":"Low Carbohydrate Diet, Glycaemic Control and Quality of Life in Australian Adults With Type 1 Diabetes","status":"COMPLETED","sponsor":"Gold Coast Hospital and Health Service","startDate":"2021-01-15","conditions":"Type 1 Diabetes Mellitus","enrollment":23},{"nctId":"NCT02936687","phase":"PHASE1","title":"Mechanisms of Cerebrovascular Control","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2017-01-31","conditions":"Metabolic Syndrome X","enrollment":59},{"nctId":"NCT01860911","phase":"PHASE1","title":"Plasma Triglyceride Extraction by The Muscle","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2013-04","conditions":"Obesity, Insulin Resistance","enrollment":33},{"nctId":"NCT03620890","phase":"PHASE4","title":"Detemir Versus NPH for Type 2 Diabetes Mellitus in Pregnancy","status":"COMPLETED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2018-09-04","conditions":"Diabetes Mellitus, Type 2","enrollment":108},{"nctId":"NCT02964104","phase":"PHASE1","title":"A Trial Investigating the Safety, Tolerability, Pharmacokinetics (the Exposure of the Trial Drug in the Body) and Pharmacodynamics (the Effect of the Investigated Drug on the Body) of Insulin 287 in Subjects With Type 2 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2016-11-15","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":50},{"nctId":"NCT03389490","phase":"PHASE4","title":"Toujeo Versus NPH Self-titration Study","status":"COMPLETED","sponsor":"Elaine Chow","startDate":"2018-01-01","conditions":"Diabetes Mellitus, Type 2","enrollment":50},{"nctId":"NCT03285217","phase":"NA","title":"HMB for Denutrition in Patients With Cirrhosis (HEPATIC)","status":"COMPLETED","sponsor":"Instituto Aragones de Ciencias de la Salud","startDate":"2017-10-15","conditions":"Sarcopenia, Cirrhosis, Malnutrition","enrollment":43},{"nctId":"NCT04664764","phase":"PHASE4","title":"Intermediate and Long Acting Insulin Young Children Type 1 Diabetes.","status":"UNKNOWN","sponsor":"Ain Shams University","startDate":"2019-02-21","conditions":"Type 1 Diabetes Mellitus With Hypoglycemia, type1diabetes","enrollment":60},{"nctId":"NCT04726657","phase":"NA","title":"Comparison of Two Biphasic Insulin Regimens","status":"COMPLETED","sponsor":"Aristotle University Of Thessaloniki","startDate":"2016-01-18","conditions":"Diabetes Mellitus, Type 2","enrollment":36},{"nctId":"NCT04726631","phase":"NA","title":"Insulin in Treatment of Diabetes Mellitus With Pregnancy","status":"COMPLETED","sponsor":"Assiut University","startDate":"2015-01-01","conditions":"Diabetes","enrollment":110},{"nctId":"NCT04690309","phase":"PHASE4","title":"Human Versus Analogue Insulin in Patients After Pancreatectomy.","status":"UNKNOWN","sponsor":"Polish Society of Diabetology","startDate":"2018-07-01","conditions":"Pancreatogenous Diabetes","enrollment":100},{"nctId":"NCT04635202","phase":"NA","title":"Effect of Elliptical Training on Metabolic Homeostasis in Metabolic Syndrome","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2020-09-09","conditions":"Metabolic Syndrome","enrollment":60},{"nctId":"NCT02486341","phase":"NA","title":"Daily Glycaemic Variability in Frail or Disabled Older Patients With Diabetes Over 75 Treated With Basal Insulin","status":"COMPLETED","sponsor":"University Hospital, Bordeaux","startDate":"2016-03-31","conditions":"Diabetes","enrollment":30},{"nctId":"NCT03511521","phase":"PHASE4","title":"Use of NPH Versus Basal Bolus Insulin for Steroid Induced Hyperglycemia","status":"TERMINATED","sponsor":"Northwestern University","startDate":"2018-03-27","conditions":"Hyperglycemia Steroid-induced, Insulin Resistance, Diabetes","enrollment":3},{"nctId":"NCT01386645","phase":"NA","title":"Effect of Dietary Glycemic Index on Beta-cell Function","status":"COMPLETED","sponsor":"Seattle Institute for Biomedical and Clinical Research","startDate":"2011-07","conditions":"Impaired Glucose Tolerance, Oxidative Stress, Prediabetes","enrollment":56},{"nctId":"NCT02754076","phase":"PHASE1, PHASE2","title":"A Treatment Study of Mucopolysaccharidosis Type IIIB","status":"COMPLETED","sponsor":"Allievex Corporation","startDate":"2016-04","conditions":"MPS III B, Mucopolysaccharidosis Type IIIB","enrollment":23},{"nctId":"NCT04501250","phase":"NA","title":"Comparative Study of Rinsulin® NPH, Suspension for Subcutaneous Administration, 100 IU/ml (GEROPHARM LLC, Russia) and Humulin® NPH, Suspension for Subcutaneous Administration, 100 IU/ml (Lilly France, France) Using the Euglycemic Hyperinsulinemic Clamp Method","status":"COMPLETED","sponsor":"Geropharm","startDate":"2017-10-23","conditions":"Pharmacokinetics, Bioequivalence","enrollment":52},{"nctId":"NCT02634528","phase":"PHASE1","title":"Pharmacokinetic (PK) Bioequivalence and Pharmacodynamics (PD) of Julphar Insulin N and Huminsulin® Basal","status":"COMPLETED","sponsor":"Julphar Gulf Pharmaceutical Industries","startDate":"2016-11-16","conditions":"Diabetes Mellitus","enrollment":85},{"nctId":"NCT04374292","phase":"NA","title":"Dietary Habits and Metabolic Response in Obese Children Whose Mothers Received an Intervention to Promote Healthy Eating","status":"COMPLETED","sponsor":"Hospital Infantil de Mexico Federico Gomez","startDate":"2011-01-05","conditions":"Obesity, Child Obesity","enrollment":177},{"nctId":"NCT04371133","phase":"","title":"Anti-inflammatory Markers in Endometrioma","status":"COMPLETED","sponsor":"Muğla Sıtkı Koçman University","startDate":"2018-08-15","conditions":"Endometrioma, Inflammation","enrollment":48},{"nctId":"NCT03902327","phase":"NA","title":"N-acetyl-cysteine and Carbohydrate Metabolism Disorder in Obese Women","status":"UNKNOWN","sponsor":"Poznan University of Life Sciences","startDate":"2020-01-17","conditions":"Insulin Resistance, Obesity, Carbohydrate Metabolism Disorder","enrollment":30}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[{"date":"20011219","type":"SUPPL","sponsor":"NOVO NORDISK INC","applicationNumber":"BLA019959"},{"date":"19940523","type":"SUPPL","sponsor":"NOVO NORDISK INC","applicationNumber":"BLA019959"},{"date":"20000615","type":"SUPPL","sponsor":"NOVO NORDISK INC","applicationNumber":"BLA019959"},{"date":"20020411","type":"SUPPL","sponsor":"NOVO NORDISK INC","applicationNumber":"BLA019959"},{"date":"19940107","type":"SUPPL","sponsor":"NOVO NORDISK INC","applicationNumber":"BLA019959"},{"date":"20000316","type":"SUPPL","sponsor":"NOVO NORDISK INC","applicationNumber":"BLA019959"},{"date":"20180601","type":"SUPPL","sponsor":"NOVO NORDISK INC","applicationNumber":"BLA019959"},{"date":"19960808","type":"SUPPL","sponsor":"NOVO NORDISK INC","applicationNumber":"BLA019959"},{"date":"20001213","type":"SUPPL","sponsor":"NOVO NORDISK INC","applicationNumber":"BLA019959"},{"date":"20221123","type":"SUPPL","sponsor":"NOVO NORDISK INC","applicationNumber":"BLA019959"},{"date":"19980724","type":"SUPPL","sponsor":"NOVO NORDISK INC","applicationNumber":"BLA019959"},{"date":"20160108","type":"SUPPL","sponsor":"NOVO NORDISK INC","applicationNumber":"BLA019959"},{"date":"19950522","type":"SUPPL","sponsor":"NOVO NORDISK INC","applicationNumber":"BLA019959"},{"date":"20011217","type":"SUPPL","sponsor":"NOVO NORDISK INC","applicationNumber":"BLA019959"},{"date":"20100625","type":"SUPPL","sponsor":"NOVO NORDISK INC","applicationNumber":"BLA019959"},{"date":"19970620","type":"SUPPL","sponsor":"NOVO NORDISK INC","applicationNumber":"BLA019959"},{"date":"20150225","type":"SUPPL","sponsor":"NOVO NORDISK INC","applicationNumber":"BLA019959"},{"date":"19911007","type":"SUPPL","sponsor":"NOVO NORDISK INC","applicationNumber":"BLA019959"},{"date":"19940103","type":"SUPPL","sponsor":"NOVO NORDISK INC","applicationNumber":"BLA019959"},{"date":"20090717","type":"SUPPL","sponsor":"NOVO NORDISK INC","applicationNumber":"BLA019959"},{"date":"19970102","type":"SUPPL","sponsor":"NOVO NORDISK INC","applicationNumber":"BLA019959"},{"date":"20130309","type":"SUPPL","sponsor":"NOVO NORDISK INC","applicationNumber":"BLA019959"},{"date":"19940623","type":"SUPPL","sponsor":"NOVO NORDISK INC","applicationNumber":"BLA019959"},{"date":"20100625","type":"SUPPL","sponsor":"NOVO NORDISK INC","applicationNumber":"BLA019959"},{"date":"19940531","type":"SUPPL","sponsor":"NOVO NORDISK INC","applicationNumber":"BLA019959"},{"date":"20020619","type":"SUPPL","sponsor":"NOVO NORDISK INC","applicationNumber":"BLA019959"},{"date":"19910701","type":"ORIG","sponsor":"NOVO NORDISK INC","applicationNumber":"BLA019959"},{"date":"20010221","type":"SUPPL","sponsor":"NOVO NORDISK INC","applicationNumber":"BLA019959"},{"date":"20020415","type":"SUPPL","sponsor":"NOVO NORDISK INC","applicationNumber":"BLA019959"},{"date":"19940426","type":"SUPPL","sponsor":"NOVO NORDISK INC","applicationNumber":"BLA019959"},{"date":"20000410","type":"SUPPL","sponsor":"NOVO NORDISK INC","applicationNumber":"BLA019959"},{"date":"19970410","type":"SUPPL","sponsor":"NOVO NORDISK INC","applicationNumber":"BLA019959"},{"date":"20010109","type":"SUPPL","sponsor":"NOVO NORDISK INC","applicationNumber":"BLA019959"},{"date":"19930326","type":"SUPPL","sponsor":"NOVO NORDISK INC","applicationNumber":"BLA019959"},{"date":"19991018","type":"SUPPL","sponsor":"NOVO NORDISK INC","applicationNumber":"BLA019959"},{"date":"19970128","type":"SUPPL","sponsor":"NOVO NORDISK INC","applicationNumber":"BLA019959"},{"date":"20020311","type":"SUPPL","sponsor":"NOVO NORDISK INC","applicationNumber":"BLA019959"},{"date":"19930326","type":"SUPPL","sponsor":"NOVO NORDISK INC","applicationNumber":"BLA019959"},{"date":"19970804","type":"SUPPL","sponsor":"NOVO NORDISK INC","applicationNumber":"BLA019959"},{"date":"19940104","type":"SUPPL","sponsor":"NOVO NORDISK INC","applicationNumber":"BLA019959"},{"date":"19920313","type":"SUPPL","sponsor":"NOVO NORDISK INC","applicationNumber":"BLA019959"},{"date":"20191115","type":"SUPPL","sponsor":"NOVO NORDISK INC","applicationNumber":"BLA019959"},{"date":"19970416","type":"SUPPL","sponsor":"NOVO NORDISK INC","applicationNumber":"BLA019959"},{"date":"20180601","type":"SUPPL","sponsor":"NOVO NORDISK INC","applicationNumber":"BLA019959"},{"date":"19940623","type":"SUPPL","sponsor":"NOVO NORDISK INC","applicationNumber":"BLA019959"},{"date":"20090615","type":"SUPPL","sponsor":"NOVO NORDISK INC","applicationNumber":"BLA019959"},{"date":"19940616","type":"SUPPL","sponsor":"NOVO NORDISK INC","applicationNumber":"BLA019959"},{"date":"20101227","type":"SUPPL","sponsor":"NOVO NORDISK INC","applicationNumber":"BLA019959"},{"date":"20020110","type":"SUPPL","sponsor":"NOVO NORDISK INC","applicationNumber":"BLA019959"}],"publicationCount":2,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Novolin N","genericName":"Novolin N","companyName":"Wockhardt","companyId":"wockhardt","modality":"Biologic","firstApprovalDate":"","aiSummary":"Novolin N is an intermediate-acting insulin that binds to insulin receptors on cells to facilitate glucose uptake and utilization, lowering blood glucose levels. Used for Type 1 diabetes mellitus, Type 2 diabetes mellitus.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}